Trade Summary

6 days ago, Reich Kristian, serving as Chief Scientific Officer at MoonLake Immunotherapeutics (MLTX), sold 43,700 shares at $20.09 per share, for a total transaction value of $877,933.00. Following this transaction, Reich Kristian now holds 2,764,746 shares of MLTX.

This sale represents a 1.56% decrease in Reich Kristian's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, July 20, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, July 21, 2026 at 6:13 PM ET, 1 day after the trade was made.

MoonLake Immunotherapeutics operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.